Skip to content
Menu

TScan Therapeutics, Inc. TCRX

Full chart Compare
Set alert

Price alert · TCRX

All alert types
0.14 USD -0.01 (-3.84%)

Regular-session close

0.15 +0.01 +4.98%

After hours · Nov 19, 6:41 PM ET

0.1401 Day range 0.157
0.14 52-week range 1.47
YTD
-85.73%
1 year
-86.15%

Revenue & Expenses

Revenue Profit Costs
Other Income$6.05MOther Operating Income$2.87MGross Profit$7.46MNet Loss$129.77MCost of Revenue$2.87MExpenses$146.14MSelling, General & Admin$31.99MResearch & Development$114.15MRevenue$10.32M

Latest period ending Dec 31, 2025 · select a line to chart its full history

TCRX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
10.32M2.82M21.05M13.54M10.14M
10.32M2.82M21.05M13.54M10.14M
-135.81M-134.82M-93.46M-66.64M-48.64M
-129.77M-127.50M-89.22M-66.22M-48.63M
-1.00-1.14-1.36-2.75-4.17
TCRX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
157.44M183.72M138.39M125.06M166.44M
228.79M371.12M272.15M199.09M188.11M
105.67M130.15M121.28M99.66M27.33M
94.14M97.38M92.43M85.98M6.04M
123.12M240.97M150.87M99.43M160.78M
TCRX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-135.32M-110.82M-61.36M-66.50M-48.68M
109.37M-52.61M-60.76M-4.22M-9.94M
-336.00K208.76M135.44M29.36M189.67M
-4.41M-3.83M-3.15M-4.22M-9.94M
-26.28M45.33M13.33M-41.37M131.05M